Flossbach Von Storch Ag Abbott Laboratories Transaction History

Flossbach Von Storch Ag

$22.9 Billion
Q1 2024

A detailed history of Flossbach Von Storch Ag transactions in Abbott Laboratories stock. As of the latest transaction made, Flossbach Von Storch Ag holds 8,573,419 shares of ABT stock, worth $876 Million. This represents 4.25% of its overall portfolio holdings.

Number of Shares

8,573,419

Previous 9,149,611 6.3%

Holding current value

$876 Million

Previous $1.01 Billion 3.24%

% of portfolio

4.25%

Previous 4.61%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $63.1 Million - $69.7 Million	-576,192 Reduced 6.3%	8,573,419 $974 Million
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $12.2 Million - $15 Million	135,821 Added 1.51%	9,149,611 $1.01 Billion
Q3 2023 Oct 27, 2023	BUY	$95.53 - $114.62 $70.8 Million - $85 Million	741,441 Added 8.96%	9,013,790 $873 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $4.18 Million - $4.66 Million	41,485 Added 0.5%	8,272,349 $902 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $39.2 Million - $46.1 Million	404,346 Added 5.17%	8,230,864 $833 Million

Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $42.3 Million - $49.7 Million	445,359 Added 6.03%	7,826,518 $859 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $8.2 Million - $9.49 Million	84,738 Added 1.16%	7,381,159 $714 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $21.9 Million - $26.5 Million	214,839 Added 3.03%	7,296,421 $793 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $124 Million - $151 Million	1,088,770 Added 18.17%	7,081,582 $838 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $19.9 Million - $24.3 Million	172,068 Added 2.96%	5,992,812 $843 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $51.8 Million - $57.3 Million	-443,828 Reduced 7.08%	5,820,744 $688 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $169 Million - $199 Million	1,600,139 Added 34.31%	6,264,572 $726 Million
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $9.9 Million - $11.7 Million	90,928 Added 1.99%	4,664,433 $559 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $17.6 Million - $19.2 Million	167,868 Added 3.81%	4,573,505 $501 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $706,177 - $857,600	7,706 Added 0.18%	4,405,637 $479 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $80.3 Million - $103 Million	-1,048,801 Reduced 19.26%	4,397,931 $402 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $135 Million - $197 Million	2,143,839 Added 64.91%	5,446,732 $430 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $10.4 Million - $11.5 Million	131,942 Added 4.16%	3,302,893 $287 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $2.08 Million - $2.26 Million	25,446 Added 0.81%	3,170,951 $265 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $4.39 Million - $5.12 Million	-60,235 Reduced 1.88%	3,145,505 $265 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $140 Million - $169 Million	-2,109,144 Reduced 39.68%	3,205,740 $256 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $54.8 Million - $62.1 Million	-835,871 Reduced 13.59%	5,314,884 $384 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $16 Million - $19.3 Million	-263,270 Reduced 4.1%	6,150,755 $451 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $710,125 - $783,765	12,335 Added 0.19%	6,414,025 $391 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $151 Million - $170 Million	-2,678,990 Reduced 29.5%	6,401,690 $384 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $115 Million - $123 Million	-2,141,329 Reduced 19.08%	9,080,680 $518 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $539 Million - $602 Million	11,222,009	11,222,009 $599 Million

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

News

Stay updated on Flossbach Von Storch Ag with notifications on news.

Account

Flossbach Von Storch Ag Abbott Laboratories Transaction History